Spotlight on New Hotels


Pfizer Posts Record Revenue with COVID Antiviral, Vaccine Sales


Pfizer posted a record revenue in the second quarter of 2022 with sales of COVID-19 antiviral treatment Paxlovid and vaccines, according to its financial results statement released on Thursday.

The US-based pharmaceutical company earned $8.8 billion from its COVID-19 vaccines, and $8.1 billion from its oral medication Paxlovid.

This carried the company's total revenue to $27.7 billion in the second quarter, which is up 46.5% from $18.9 billion the same period of last year.

Net income jumped approximately 80% to $9.9 billion, from $5.5 billion, during that period.

Chairman and CEO Albert Bourla said the company launched an initiative to bring its patented medicines and vaccines to 1.2 billion people living in 45 lower-income countries around the world at not-for-profit prices.



The company reaffirmed its 2022 total revenue expectations for its COVID-19 vaccine sales at $32 billion and $22 billion for Paxlovid.

Pfizer and its German partner BioNTech announced on June 29 to provide the US government with 105 million doses of vaccine for $3.2 billion.

While the US government also has the option to purchase up to 195 million additional doses, the deal may include adult omicron-adapted COVID-19 vaccine that is subject to authorization from the Food and Drug Administration.

Source: AA


Latest Travel News

Lindner Hotels

Germany's Lindner Hotels and Resorts Join Hyatt

June 09, 2023 Accommodation
Hyatt Hotels Corporation announced that as part of Hyatt’s strategic collaboration with German hospitality company Lindner Hotels AG, properties of the brands ‘Lindner Hotels & Resorts’ and ‘me and all hotels’ are joining World of Hyatt as part of the JdV by…